Although there was a decrease in the maximum PED height following the third intravitreal faricimab injection (from 205.3 ± 107.5 μm to 178.5 ± 89.1 μm), this change did not reach statistical significance ( P = 0.8) (Fig. 1 C).
← all excerpts
Switch to faricimab after initial treatment with aflibercept in eyes with neovascular age-related macular degeneration.
1
0.8000
0.8000